Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-127–35
- 14 January 2008
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 126 (3) , 251-259
- https://doi.org/10.1016/j.clim.2007.11.011
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Activation‐induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis‐inducing factorEuropean Journal of Immunology, 2006
- Lentiviral-mediated delivery of siRNAs for antiviral therapyGene Therapy, 2006
- Activation of the mammalian immune system by siRNAsNature Biotechnology, 2005
- Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cellsImmunology, 2004
- Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocationEuropean Journal of Immunology, 2004
- Dendritic cell subsets and the regulation of Th1/Th2 responsesSeminars in Immunology, 2001
- RNAiCell, 2000
- Stimulatory and Inhibitory Differentiation of Human Myeloid Dendritic CellsClinical Immunology, 2000
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytesEuropean Journal of Immunology, 1994